Oral-Parenteral Conversion Factor for Morphine in Palliative Cancer Care: A Prospective Randomized Crossover Pilot Study

Objective. This pilot study clinically tests whether a conversion factor of 2 to 1 is appropriate when changing from oral to parenteral morphine administration in the treatment of cancer-related nociceptive pain and calculates the size of an adequately powered future study. Methods. Eleven outpatien...

Descripción completa

Detalles Bibliográficos
Autores principales: Starlander, Jan, Melin-Johansson, Christina, Jonsson, Håkan, Axelsson, Bertil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197012/
https://www.ncbi.nlm.nih.gov/pubmed/22110926
http://dx.doi.org/10.1155/2011/504034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197012/
https://www.ncbi.nlm.nih.gov/pubmed/22110926
http://dx.doi.org/10.1155/2011/504034

Ejemplares similares